Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Management of the Patient with Stable Ischemic Heart Disease and Preserved Left Ventricular Systolic Function

Slide: 19 of 21

Patient Followup: Potential Benefits of ARBs

Upon further review of the consumer guide with the patient, you discuss with him the potential benefits of taking an ARB which are:

Discussion of answers:

A. Correct. Evidence suggests that ARBs can lower the composite risk of cardiovascular mortality, nonfatal myocardial infarction, or stroke better than placebo (12% relative risk reduction, number needed to treat = 56; absolute risk reduction = 1.8).

B. Incorrect. Evidence suggests that ARBs can lower the composite risk of cardiovascular mortality, nonfatal myocardial infarction, or stroke better than placebo.

C. Incorrect. Evidence suggests that ARBs can lower the composite risk of cardiovascular mortality, nonfatal myocardial infarction, or stroke better than placebo.

D. Incorrect. Evidence suggests that ARBs can lower the composite risk of cardiovascular mortality, nonfatal myocardial infarction, or stroke better than placebo.